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ICD-9 Codes for
Identifying
Influenza
Hospitalizations in
Children 
To the Editor: The effect of
influenza on young children is sub-
stantial, but most infections are clini-
cally unrecognized (1). As a result,
without routine laboratory confirma-
tion of influenza infection in patients
admitted to the hospital with influen-
zalike illness, accurate estimates of
influenza-related hospitalization rates
are difficult to obtain. Several statisti-
cal models have been developed to
generate estimates of excess or
influenza attributable hospitalizations,
all of which calculate the rate of hospi-
talization above baseline during peri-
ods in which influenza is circulating
(2–8). However, their accuracy is lim-
ited when viruses such as respiratory
syncytial virus (RSV) and parainfluen-
za are cocirculating with influenza.
International Classification of
Diseases, 9th revision (ICD-9) diag-
nostic codes specific to influenza
(487.0, 487.1, and 487.8) are easily
retrieved from hospital discharge
records. However, researchers and
public health officials have rarely
used them for influenza hospitaliza-
tion surveillance, presumably because
they lack sensitivity for identifying
true influenza infections, although
this assumption has never been tested.
To determine the sensitivity and
positive predictive value of influenza-
specific ICD-9 admission or discharge
codes (487.0, 487.1, and 487.8), we
conducted a retrospective cohort
study of all patients <21 years of age
hospitalized at the Children’s Hospital
of Philadelphia with laboratory-con-
firmed influenza during 3 consecutive
influenza seasons (July 2001 through
June 2004) (9). We compared admis-
sion and discharge ICD-9 codes
with influenza laboratory results. All
specimens were initially tested by
rapid solid-phase immunoassay for
RSV (Binax; Portland, ME, USA) and
influenza (Binax). Direct fluorescent
antibody testing for adenovirus,
influenza Aand B, parainfluenza virus
types 1, 2, and 3, and RSV was per-
formed on specimens negative by
solid-phase immunoassay for RSV or
influenza. Comprehensive viral cul-
ture was established for all specimens
negative for respiratory viruses by
direct fluorescent antibody test.
Of 715 cases of laboratory-con-
firmed influenza identified (Table),
617 (86%) were identified by rapid
testing and 98 (14%) by viral culture
after rapid test results were negative.
A total of 529 patients had influenza-
specific admission or discharge ICD-
9 codes. The sensitivity of influenza-
specific ICD-9 codes was 65% (95%
confidence interval [CI] 61%–68%),
and the positive predictive value was
88% (95% CI 84%–90%) (Table). Of
66 patients who had influenza-specif-
ic admission or discharge ICD-9
codes but negative influenza laborato-
ry results, laboratory tests confirmed
parainfluenza (n = 42), Haemophilus
influenzae (n = 6; 1 with a positive
blood culture and 5 with positive res-
piratory cultures), H. parainfluenzae
(n = 1 wound infection), adenovirus
(n = 1), and RSV (n = 2) infections.
For 5 patients, influenza infection was
documented in their charts, but they
had either negative influenza test
results or no influenza test performed.
Seven patients had the expression
“follow-up” written as “f/u” in the
assessment section of their admission
note, which may have been interpret-
ed by medical coders as flu. We could
not determine the reason for miscod-
ing in 2 patients.
The sensitivity of influenza-specif-
ic diagnosis codes was related to the
method of laboratory confirmation.
Seventy-three percent (452/617) of
patients (95% CI 70%–77%) who had
positive rapid test results had influen-
za-specific admission or discharge
diagnosis codes, whereas only 11%
(11/98) (95% CI 6%–19%) who had
positive influenza viral cultures (and
negative rapid test results) had
influenza-specific diagnosis codes.
Our results have a few policy
implications. First, they suggest that
in hospitals where routine influenza
viral testing is performed, use of
admission and discharge ICD-9 codes
from hospital billing data for surveil-
lance purposes will systematically
underestimate actual influenza-related
hospitalizations by 35%. The higher
sensitivity of influenza-specific ICD-9
codes in patients with positive rapid
test results compared with positive
culture results suggests that unlike
viral culture results, which generally
are not available before discharge,
rapid test results are often used to
assign influenza-specific ICD-9
codes. Thus, rapid diagnostic tests
that are more sensitive (e.g., PCR-
based assays) may increase the sensi-
tivity of influenza-specific ICD-9
codes in hospitals that routinely eval-
uate children admitted with respirato-
ry symptoms of unclear cause.
However, the imperfect specificity
(94%–98%) of rapid influenza tests
will produce a small but not negligible
number of false-positive results. In
hospitals where influenza testing is
not commonly performed, the sensi-
tivity of influenza-specific ICD-9
codes is likely to be lower. 
Second, the high positive predic-
tive value of influenza-specific ICD-9
Table. Influenza-specific admission or discharge ICD-9 codes (487.0, 487.1, and 487.8.) 
compared with influenza laboratory test results* 
Parameter  LCI  No LCI  Total 
Influenza-specific diagnosis codes  463  66  529 
No influenza-specific diagnosis codes  252  –  – 
Total  715  –  – 
*ICD-9, International Classification of Diseases-9; LCI, laboratory-confirmed influenza. The sensitivity 
and positive predictive value of influenza-specific diagnosis codes were 65% and 88%, respectively. LETTERS
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codes observed in this study suggests
that in hospitals where influenza test-
ing is routinely performed, most
patients whose hospitalization sum-
mary includes an influenza-specific
ICD-9 code actually have influenza.
However, misclassification of patients
with parainfluenza and H. influenzae
infections as patients with influenza
demonstrates the potential for system-
atic coding errors even when influen-
za testing is routine. 
Epidemiologists and public health
officials should be aware that influen-
za-specific ICD-9 codes assigned in a
setting of routine rapid diagnostic
testing may be useful for following
trends. However, these codes will
substantially underestimate the actual
number of influenza-related hospital-
izations.
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Chikungunya Virus
Strains, Reunion
Island Outbreak
To the Editor: Chikungunya virus
(CHIKV) is endemic in rural tropical
Africa and is penetrating urban areas
in Asia. CHIKV is maintained in a
sylvatic cycle that involves mosqui-
toes of the genus Aedes, primates, and
rodents. CHIKV infection induces
fever, arthralgia, and maculopapular
rash. Hemorrhagic complications
have been reported in some outbreaks,
but a more specific symptom is severe
arthralgia, often persistent, which
results in long-lasting disability.
After numerous cases of CHIKV
infection had been reported in
Comoros and Mauritius (1), an out-
break of febrile illness was reported
on Reunion Island in March 2005 (2).
The incidence of the disease remained
relatively low until December 2005,
when it increased dramatically. The
outbreak resulted in >3,500 confirmed
cases and an estimated 250,000 sus-
pected cases (2), affecting >25% of
the island’s inhabitants. Encephalitic
forms were reported on many occa-
sions during the active phase of the
outbreak, and >200 persons died
while they were infected with
CHIKV. Previously unreported com-
plications, such as mother-to-child
transmission, myocarditis, hepatitis,
and extensive dermal lesions were
also encountered.
Many samples, collected from
patients during the outbreak, were
sent to our laboratory (Virology Unit,
Tropical Institute of the French
Armed Forces Medical Service,
Marseille, France) to identify the etio-
logic agent. Serum samples incubated
with C6/36 cells according to previ-
ously published methods (3) yielded
CHIKV. This virus was also isolated
from cerebrospinal fluid collected
from a patient with encephalitis, from
corneas collected from asymptomatic
human organ donors, and from pools
of mosquitoes (Aedes albopictus and
Culex quinquefasciatus) collected on
the island.
Five isolates were partially
sequenced. The CHIKV genome was
partly amplified by using the specific
primer pair OP16/OP17 (4), and
reverse transcription (RT)-PCR prod-
ucts (1,200 nucleotides long) were
cloned and sequenced (GenBank
accession nos. DQ462746–
DQ462750). Comparison of partial